Literature DB >> 1648694

Motor activity and the GABAA-receptor in the ventral pallidum/substantia innominata complex.

R van den Bos1, A R Cools.   

Abstract

The present study deals with the role of the gamma-aminobutyric acid-A (GABAA) receptor in motor activity in the rostral part of the ventral pallidum/substantia innominata complex. Both the specific GABAA antagonist bicuculline (25-100 ng/0.5 microliter) and the GABAA agonist muscimol (25 ng/0.5 microliter) enhanced motor activity. It was moreover found that bicuculline (50-100 ng) dose-dependently attenuated the activity induced by muscimol (25 ng). Conversely, muscimol (25 ng) attenuated the bicuculline (25-50 ng) induced activity. These data thus show that both stimulation and blockade of GABAA receptors within the area under study enhance motor activity.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1648694     DOI: 10.1016/0304-3940(91)90105-3

Source DB:  PubMed          Journal:  Neurosci Lett        ISSN: 0304-3940            Impact factor:   3.046


  4 in total

1.  Lateral preoptic and ventral pallidal roles in locomotion and other movements.

Authors:  Suriya Subramanian; Rhett A Reichard; Hunter S Stevenson; Zachary M Schwartz; Kenneth P Parsley; Daniel S Zahm
Journal:  Brain Struct Funct       Date:  2018-04-26       Impact factor: 3.270

2.  Desynchronized (REM) sleep inhibition induced by carbachol microinjections into the nucleus basalis of Meynert is mediated by the glutamatergic system.

Authors:  A Manfridi; M Mancia
Journal:  Exp Brain Res       Date:  1996-04       Impact factor: 1.972

3.  Opioid and GABA modulation of accumbens-evoked ventral pallidal activity.

Authors:  J J Chrobak; T C Napier
Journal:  J Neural Transm Gen Sect       Date:  1993

4.  Ventral pallidal GABAergic neurons control wakefulness associated with motivation through the ventral tegmental pathway.

Authors:  Ya-Dong Li; Yan-Jia Luo; Wei Xu; Jing Ge; Yoan Cherasse; Yi-Qun Wang; Michael Lazarus; Wei-Min Qu; Zhi-Li Huang
Journal:  Mol Psychiatry       Date:  2020-10-14       Impact factor: 15.992

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.